Fit2ThriveMB: Optimization of a Physical Activity Promotion Intervention for Metastatic Breast Cancer Patients
Part of paid clinical trials in Chicago, Illinois.
- Sponsor
- Northwestern University
- Study ID
- NCT07840599
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Metastatic Breast Cancer
- Metastatic Breast Cancer (MBC)
- Metastatic Breastcancer
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Core Intervention — BEHAVIORALThe core intervention includes educational materials, Fitbit and access to the Fit2ThriveMB Core App.
- EHR Integration (On v. Off) — BEHAVIORALParticipant Fitbit data will synchronize with the EHR. Participants will receive automated weekly messages via the patient portal. Clinicians can view patient Fitbit data and will receive Epic InBasket messages on the day of patient appointments with a summary of patients' PA progress and talking points to encourage patients.
- Weekly Coaching — BEHAVIORALParticipants will receive 12 calls from study staff to provide feedback on PA progress and support to increase PA.
- Social+ (on v. off) — BEHAVIORALParticipants assigned to this condition will receive the social feed app module and attend 7 synchronous, facilitated group sessions during the 12-week intervention. There will also be a social feed app module is intended to enhance communication and support among participants.
- Static Goal Setting — BEHAVIORALParticipants will be provided with a daily step goal for the week. The goal will be progressive and tailored to each individual's progress to build efficacy and ensure safe progression until 10,000 steps/day is achieved (i.e. 4500 steps/day in week 1, 5500 steps/day in week 2, etc.).
- Bi-Weekly Coaching — BEHAVIORALParticipants will receive 6 calls from study staff to provide feedback on PA progress and support to increase PA.
- Highly Tailored Goal Setting — BEHAVIORALParticipants will be prompted each morning to report the intensity of their symptom burden on a scale from 1 to 5. Based on symptom rating, prior day's step goal attainment and/or the number of steps achieved the previous day, participants will be provided with three to four goal options for that day.
Study Details
The purpose of this study is to examine which of four components of a digital health intervention using an App and Fitbit meaningfully contribute to increased physical activity in Metastatic Breast Cancer Patients. Participants will be asked to: * Wear a Fitbit and use an app, use 0 to 3 other components for 24 weeks and attend 6 or 12 coaching coaching calls in the first 12 weeks to increase daily steps. * Complete a questionnaire at baseline, week 12 and week 24 * Complete functional performance test (FPT) via Zoom at baseline, week 12 and week 24 * Wear a research activity monitor (Accelerometer) for 7 days at baseline, week 12 and week 24
Key Dates
- First listed
- Sep 25, 2026
- Start date
- Jan 1, 2027
- Status verified
- Sep 2026
- Primary completion
- Jan 1, 2031
- Completion
- Jun 15, 2031
Study Design
- Enrollment
- 224 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- FACTORIAL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: 1- Core, EHR, Weekly Coaching, Social+, Highly Tailored Goal Setting
- Experimental: 2- Core, EHR, Bi-Weekly Coaching, Social+, Highly Tailored Goal Setting
- Experimental: 3- Core, EHR, Weekly Coaching, Static Goal Setting
- Experimental: 4- Core, EHR, Bi-Weekly Coaching, Static Goal Setting
- Experimental: 5- Core, EHR, Weekly Coaching, Social+, Static Goal Setting
- Experimental: 6- Core, EHR, Bi-Weekly Coaching, Social+, Static Goal Setting
- Experimental: 7- Core, EHR, Weekly Coaching, Highly Tailored Goal Setting
- Experimental: 8- Core, EHR, Bi-Weekly Coaching, Highly Tailored Goal Setting
- Experimental: 9- Core, Weekly Coaching, Social+, Static Goal Setting
- Experimental: 10- Core, Bi-Weekly Coaching, Social+, Static Goal Setting
- Experimental: 11- Core, Weekly Coaching, Highly Tailored Goal Setting
- Experimental: 12- Core, Bi-Weekly Coaching, Highly Tailored Goal Setting
- Experimental: 13- Core, Weekly Coaching, Social+, Highly Tailored Goal Setting
- Experimental: 14- Core, Bi-Weekly Coaching, Social+, Highly Tailored Goal Setting
- Experimental: 15- Core, Weekly Coaching, Static Goal Setting
- Experimental: 16- Core, Bi-Weekly Coaching, Static Goal Setting
Primary Outcome Measure
Change in Steps [ Time Frame: Baseline, 12 and 24 weeks ]
Central Contacts
- Siobhan Phillips, PhD312-503-4235
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Northwestern University | Chicago | Illinois | 60611 |
Find similar trials in Chicago, IL
Related Studies
- A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast CancerPHASE1/PHASE2 · Recruiting · Hoffmann-La Roche · Duarte, California
- CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast CancerPHASE1 · Recruiting · University of Texas Southwestern Medical Center · Chicago, Illinois
- First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast CancerPHASE1 · Recruiting · Relay Therapeutics, Inc. · Tucson, Arizona
- Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Patients With a PI3K Alteration and HR+/Her2- Breast CancerPHASE1/PHASE2 · Recruiting · SynDevRx, Inc. · Loma Linda, California